MACC1 and colorectal carcinoma: Surprisingly, treating CRC cell lines with the proliferation inhibitor mitomycin abolished the MACC1-associated effect on the collective migration speed, indicating that targeting proliferation in MACC1high expressing tumors might allow additional effects on cell migration [220].